Tuesday’s Analyst Ratings: Upgrades and Downgrades
Analyst ratings are crucial indicators for investors wanting to gauge market sentiment. On Tuesday, a series of upgrades and downgrades were issued by various financial institutions, highlighting notable movements in different sectors, particularly energy and healthcare.
Energy Sector Analyst Ratings
Whitecap Resources Inc. (WCP-T) received notable attention from TD Cowen analyst Aaron Bilkoski, who believes its diversified portfolio positions the company advantageously for future growth. After exceeding production expectations with a fourth-quarter output of 379,606 barrels of oil equivalent per day, shares of Whitecap closed up 1.3% on Monday. Bilkoski raised the target price for Whitecap from $13 to $15 while maintaining a “buy” rating.
- Fourth Quarter Production: 379,606 BOE/d, exceeding Bilkoski’s estimate of 371,000 and Street’s 371,600.
- Cash Flow per Share: 72 cents, above the estimated range of 65-67 cents.
- Dividend Yield: Expected at 5% with additional free cash flow supporting share repurchases.
Raymond James analyst Luke Davis downgraded Whitecap from “strong buy” to “outperform,” raising the target from $15 to $16. Davis cited strong management performance and integration success from the recent acquisition of Veren Inc. Meanwhile, BMO’s Jeremy McCrea, ATB Cormark’s Patrick O’Rourke, and Canaccord Genuity’s Mike Mueller each increased their targets for Whitecap to a range of $15 to $15.50, emphasizing the company’s diverse asset base.
Healthcare Sector Ratings
In the healthcare sector, TD Cowen analyst David Kwan expressed a cautious outlook for healthcare software providers amidst rising concerns about artificial intelligence. Kwan reduced his price targets for VitalHub (VHI-T) to $13 from $15 and for Well Health Technologies Corp. (WELL-T) to $7 from $7.50, noting WELL remains a top pick for 2026.
